These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 20464527)

  • 1. α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment.
    George S; Mok SS; Nurjono M; Ayton S; Finkelstein DI; Masters CL; Li QX; Culvenor JG
    J Mol Neurosci; 2010 Oct; 42(2):243-54. PubMed ID: 20464527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.
    Betarbet R; Canet-Aviles RM; Sherer TB; Mastroberardino PG; McLendon C; Kim JH; Lund S; Na HM; Taylor G; Bence NF; Kopito R; Seo BB; Yagi T; Yagi A; Klinefelter G; Cookson MR; Greenamyre JT
    Neurobiol Dis; 2006 May; 22(2):404-20. PubMed ID: 16439141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease.
    Hennis MR; Marvin MA; Taylor CM; Goldberg MS
    Neurobiol Dis; 2014 Feb; 62():113-23. PubMed ID: 24075852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Bian M; Liu J; Hong X; Yu M; Huang Y; Sheng Z; Fei J; Huang F
    PLoS One; 2012; 7(6):e39953. PubMed ID: 22792139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of DJ-1 in Parkinson's disease.
    Lev N; Roncevic D; Ickowicz D; Melamed E; Offen D
    J Mol Neurosci; 2006; 29(3):215-25. PubMed ID: 17085780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
    Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral upregulation of α-synuclein expression in the mouse substantia nigra by intracranial rotenone treatment.
    Carriere CH; Kang NH; Niles LP
    Exp Toxicol Pathol; 2017 Feb; 69(2):109-114. PubMed ID: 27986376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.
    De Miranda BR; Rocha EM; Bai Q; El Ayadi A; Hinkle D; Burton EA; Timothy Greenamyre J
    Neurobiol Dis; 2018 Jul; 115():101-114. PubMed ID: 29649621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotenone-induced parkinsonism elicits behavioral impairments and differential expression of parkin, heat shock proteins and caspases in the rat.
    Sonia Angeline M; Chaterjee P; Anand K; Ambasta RK; Kumar P
    Neuroscience; 2012 Sep; 220():291-301. PubMed ID: 22710069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recessive Parkinson's disease.
    Kubo S; Hattori N; Mizuno Y
    Mov Disord; 2006 Jul; 21(7):885-93. PubMed ID: 16615060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A highly reproducible rotenone model of Parkinson's disease.
    Cannon JR; Tapias V; Na HM; Honick AS; Drolet RE; Greenamyre JT
    Neurobiol Dis; 2009 May; 34(2):279-90. PubMed ID: 19385059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinsonian rotenone mouse model: reevaluation of long-term administration of rotenone in C57BL/6 mice.
    Inden M; Kitamura Y; Abe M; Tamaki A; Takata K; Taniguchi T
    Biol Pharm Bull; 2011; 34(1):92-6. PubMed ID: 21212524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
    Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
    Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROS-dependent regulation of Parkin and DJ-1 localization during oxidative stress in neurons.
    Joselin AP; Hewitt SJ; Callaghan SM; Kim RH; Chung YH; Mak TW; Shen J; Slack RS; Park DS
    Hum Mol Genet; 2012 Nov; 21(22):4888-903. PubMed ID: 22872702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation.
    Xiong H; Wang D; Chen L; Choo YS; Ma H; Tang C; Xia K; Jiang W; Ronai Z; Zhuang X; Zhang Z
    J Clin Invest; 2009 Mar; 119(3):650-60. PubMed ID: 19229105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Developments in Genetic rat models of Parkinson's Disease.
    Creed RB; Goldberg MS
    Mov Disord; 2018 May; 33(5):717-729. PubMed ID: 29418019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Back and to the Future: From Neurotoxin-Induced to Human Parkinson's Disease Models.
    Airavaara M; Parkkinen I; Konovalova J; Albert K; Chmielarz P; Domanskyi A
    Curr Protoc Neurosci; 2020 Mar; 91(1):e88. PubMed ID: 32049438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mendelian forms of Parkinson's disease.
    Gasser T
    Biochim Biophys Acta; 2009 Jul; 1792(7):587-96. PubMed ID: 19168133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.